Shukra Pharmaceuticals Ltd.
| BSE: 524632 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE551C01028 |
| BSE 00:00 | 15 Apr | 53.95 |
2.35 (4.55%) |
OPEN
49.60 |
HIGH
54.50 |
LOW
43.30 |
| NSE 05:30 | 01 Jan | Shukra Pharmaceuticals Ltd |
| OPEN | 49.60 |
| PREVIOUS CLOSE | 51.60 |
| VOLUME | 3485 |
| 52-Week high | 56.95 |
| 52-Week low | 24.65 |
| P/E | |
| Mkt Cap.(Rs cr) | 8 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Shukra Pharmaceuticals Ltd. (SHUKRAPHARMA) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Sun Pharma.Inds. | 632.95 | 5.55 | 0.88 | 3211.14 |
| Dr Reddy's Labs | 4842.45 | 61.85 | 1.29 | 2937.70 |
| Cipla | 914.20 | 29.00 | 3.28 | 2318.17 |
| Aurobindo Pharma | 914.65 | 4.90 | 0.54 | 1872.74 |
| Cadila Health. | 504.00 | 15.45 | 3.16 | 1412.90 |
| Divi's Lab. | 3782.95 | 62.70 | 1.69 | 1372.71 |
| Glenmark Pharma. | 536.80 | 24.85 | 4.85 | 1354.55 |
| Alkem Lab | 2747.45 | -7.15 | -0.26 | 1264.42 |
| Alembic Pharma | 972.00 | -5.75 | -0.59 | 969.40 |
| Torrent Pharma. | 2566.30 | -0.10 | 0.00 | 938.51 |
| Gland Pharma | 2483.30 | -48.75 | -1.93 | 772.86 |
| Lupin | 1049.75 | 12.60 | 1.21 | 727.55 |
| Ipca Labs. | 2101.70 | -52.35 | -2.43 | 652.46 |
| Abbott India | 14941.65 | -16.85 | -0.11 | 592.93 |
| Fortis Health. | 206.15 | 5.40 | 2.69 | 513.33 |
| Pfizer | 5131.65 | 59.25 | 1.17 | 509.13 |
| Sanofi India | 8039.15 | 0.50 | 0.01 | 477.60 |
| Natco Pharma | 911.60 | -1.65 | -0.18 | 474.50 |
| Apollo Hospitals | 2990.80 | 12.40 | 0.42 | 470.30 |
| Granules India | 317.35 | -0.60 | -0.19 | 444.07 |
Quick Links for Shukra Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
